PKG drug G1

This research compound, PKG drug G1, targets the C42 residue of PKG Iα. It induces vasodilation and lowers blood pressure through mechanisms that are independent of this specific PKG Iα interaction. It is a valuable tool for studying cyclic nucleotide signaling in cardiovascular research, both in vitro and in vivo.